Albert Ferriol Monjo

Albert Ferriol obtained his bachelor’s degree in Biotechnology at the University of Lleida, Spain. During his final year, he performed a 6 month secondment at the endocrinology research group at the University of Florence where he could work in quantification and analysis of proteins as a part of his final degree thesis in metabolic dysfunctions of adipose tissue in obese patients undergoing bariatric surgery.

​

Then, he coursed his master's degree in the field of Nanoscience and Nanotechnology at the University of Barcelona (UB). His thesis was developed at the Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science (UB). He was involved in preparing and optimizing drug delivery systems and their cytotoxicity and potential selectivity towards selected non-tumoral and tumoral cell lines. The results have been published in the scientific article “Enhanced performance of gelatin 5-fluorouracil-containing nanoparticles against squamous cell carcinoma in simulated chronic wounds conditions” by the journal Materials Science and Engineering: C.

​

After presenting his final master’s project, he started working as a Research Associate in Nanomol Technologies S.L. During that period, he was working in the encapsulation of different substances in nanoparticles using supercritical fluids.

​

In 2019, he joined Medcom Advance S.A as Jr. Scientist. His research was focused on the biofunctionalization of nanostructures and their biological characterization.